Evidence map›Paper›PMID 25755827›Full record

ArticleAmerican journal of translational research2015

Potential roles of Centipede Scolopendra extracts as a strategy against EGFR-dependent cancers.

Weina Ma, Dongdong Zhang, Lei Zheng, Yingzhuan Zhan, Yanmin Zhang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Protective Effects ofBrain sciences · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Weina MaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University No. 76, Yanta Weststreet, #54, Xi'an, Shaanxi Province, P.R. China.
Dongdong ZhangSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University No. 76, Yanta Weststreet, #54, Xi'an, Shaanxi Province, P.R. China.
Lei ZhengSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University No. 76, Yanta Weststreet, #54, Xi'an, Shaanxi Province, P.R. China.
Yingzhuan ZhanSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University No. 76, Yanta Weststreet, #54, Xi'an, Shaanxi Province, P.R. China.
Yanmin ZhangSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University No. 76, Yanta Weststreet, #54, Xi'an, Shaanxi Province, P.R. China.
Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Centipede Scolopendra, a commonly used traditional Chinese medicine, has been shown to have anti-cancer effects. In this study, the inhibitory effect of alcohol extracts of Centipede Scolopendra (AECS) was more prominent when treating cells highly expressing epidermal growth factor receptor (EGFR) (A431 and HEK293/EGFR cells versus HEK293 cells). The elution profiles of AECS on cell membrane chromatography (CMC) column showed that AECS could bind to EGFR, and competition studies indicated that AECS and gefitinib may have direct competition at a single common binding site on EGFR. SiRNA knockdown of EGFR in A431 cells attenuated AECS effects, suggesting that EGFR was a target mediated by AECS. In a cell culture system, AECS dramatically induced apoptosis of A431 and HEK293/EGFR cells, which was associated with the effects on Bcl-2 family. Furthermore, AECS could alter EGFR kinase activity and reduce phosphorylation of EGFR and downstream signaling players AKT and Erk1/2. The mechanism of AECS to inhibit high-EGFR expression cell proliferation is due to its ability to induce apoptosis and modulate the EGFR pathway. This study might provide a novel therapy for cancer with high-EGFR expression.

Indexed as

apoptosiscell growthCentipede Scolopendraepidermal growth factor receptor

Identifiers

PMID25755827
PMCPMC4346522
OpenAlexW1600466766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.